RPG Life Sciences Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: RPGLIFE BSE: 532983

₹2896.40

Oct. 5, 2026 · NSE · nse_bhavcopy

Peers in Pharmaceuticals & Biotechnology

The largest companies in the same industry by market cap. This company ranks #61 of 184. PE, ROE, 1Y return and scores come from the daily/weekly precomputed snapshot.

Company	Market cap (₹ Cr)	PE (TTM)	ROE	1Y return	Div. yield	Quality	Valuation	Momentum
Sun Pharmaceutical Industries Limited	427,010	143.5	13.7%	7.6%	—	72	8	30
Divi's Laboratories Limited	244,125	83.0	15.3%	57.8%	0.33%	70	4	51
Torrent Pharmaceuticals Limited	161,506	77.7	12.2%	35.3%	0.80%	56	0	31
Zydus Lifesciences Limited	113,616	32.6	17.3%	14.5%	0.09%	74	24	84
Cipla Limited	107,888	35.1	11.2%	-11.7%	0.97%	73	29	62
Laurus Labs Limited	106,505	122.0	17.1%	128.4%	—	78	24	53
Mankind Pharma Limited	102,382	46.9	11.7%	0.9%	—	68	12	86
Dr. Reddy's Laboratories Limited	100,411	150.9	10.9%	-3.7%	—	62	33	71
RPG Life Sciences Limited (this stock)	4,790	40.1	19.0%	28.6%	0.83%	76	0	87

Valuation multiples

Current only. Market cap is the whole company's; sales/EBITDA are trailing-twelve-month standalone; debt and cash come from the latest filed standalone balance sheet (March 31, 2026). EBITDA = PBT + interest + depreciation.

Enterprise value

₹4,695 Cr

EV / EBITDA

25.6x

EV / Sales

6.39x

Market cap / Sales

6.52x

Earnings yield

2.49%

Quarterly Financials

Download CSV

Standalone Consolidated

↑ Positive

Quarterly Revenue

Jun 2026 quarterly revenue is Rs 200 Cr, up 14.8% YoY.

↑ Positive

Quarterly Net Profit

Jun 2026 quarterly net profit is Rs 31 Cr, up 16.3% YoY.

Period end	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)	Basic EPS
June 30, 2026	196	41	31	₹18.4900
March 31, 2026	177	40	30	₹18.0800
Dec. 31, 2025	180	29	22	₹13.3800
Sept. 30, 2025	182	49	37	₹22.2800
June 30, 2025	169	35	26	₹15.9000
March 31, 2025	143	135	117	₹70.9600
Dec. 31, 2024	173	47	35	₹21.1200
Sept. 30, 2024	172	15	4	₹2.5400
June 30, 2024	165	36	27	₹16.1800
March 31, 2024	127	18	13	₹8.0100
Dec. 31, 2023	154	36	26	₹16.0000
Sept. 30, 2023	154	35	26	₹15.6400
June 30, 2023	148	30	22	₹13.3600

Quarterly income statement (standalone, ₹ Cr)

Indicator	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23
Total income (before exceptional items)	200	189	183	186	174	148	176	174	168	129	156	155	150
Operating revenue	196	177	180	182	169	143	173	172	165	127	154	154	148
Other income	4	12	3	5	5	5	3	2	2	2	2	2	2
Operating expenses	152	144	140	143	133	118	124	126	126	106	116	116	116
Operating profit	44	33	40	39	35	25	49	46	39	21	38	37	32
Operating profit margin	22.3%	18.6%	22.1%	21.5%	21.0%	17.8%	28.5%	26.7%	23.6%	16.3%	24.7%	24.3%	21.8%
Depreciation	6	6	5	5	5	5	5	5	5	4	4	4	4
Interest	1	0	0	0	0	0	0	0	0	0	0	0	0
Exceptional items, gain / (loss)	—	1	-8	11	—	110	—	-27	—	—	—	—	—
Profit before tax	41	40	29	49	35	135	47	15	36	18	36	35	30
Tax	11	10	7	13	9	18	12	11	9	4	9	9	8
Net profit	31	30	22	37	26	117	35	4	27	13	26	26	22
EPS	18.49	18.08	13.38	22.28	15.90	70.96	21.12	2.54	16.18	8.01	16.00	15.64	13.36
Net profit (TTM)	119	115	203	215	183	183	79	71	92	88	85	77	72
EPS (TTM)	72.23	69.64	122.52	130.26	110.52	110.80	47.85	42.73	55.83	53.01	51.26	46.82	43.26

Total income excludes exceptional items, which are shown on their own row. Trendlyne and Screener fold exceptional items into revenue or other income, so their totals differ from this table by exactly that row.

Annual Financials

Year ended	Revenue (₹ Cr)	PBT (₹ Cr)	Net profit (₹ Cr)
March 31, 2026	708	154	115
March 31, 2025	653	233	183

Annual income statement (standalone, ₹ Cr; CAGR to the latest year)

Indicator	CAGR 3Y	CAGR 5Y	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Total income (before exceptional items)	12.3%	13.4%	733^†	666^†	589^†	518^†	443^†	390^†	376^†	331^†	348^†	305^†
Operating revenue	11.3%	12.7%	708	653	582^†	513^†	440^†	389^†	376^†	330^†	347^†	304^†
Other income	—	—	26^†	13^†	7^†	5^†	3^†	1^†	1^†	1^†	1^†	1^†
Operating expenses	—	—	560^†	494^†	454^†	410^†	354^†	319^†	316^†	297^†	310^†	274^†
Operating profit	12.7%	16.0%	147^†	160^†	128^†	103^†	86^†	70^†	59^†	33^†	38^†	31^†
Operating profit margin	—	—	20.8%^†	24.4%^†	22.0%^†	20.0%^†	19.6%^†	18.0%^†	15.7%^†	10.1%^†	10.8%^†	10.1%^†
Depreciation	—	—	21^†	21^†	17^†	16^†	16^†	16^†	16^†	15^†	14^†	12^†
Interest	—	—	1^†	1^†	0^†	0^†	1^†	1^†	2^†	4^†	4^†	3^†
Exceptional items, gain / (loss)	—	—	4^†	83^†	0^†	0^†	0^†	0^†	-5^†	0^†	0^†	7^†
Profit before tax	18.9%	23.5%	154	233	118^†	92^†	73^†	54^†	36^†	15^†	20^†	23^†
Tax	—	—	39^†	50^†	30^†	24^†	22^†	14^†	7^†	4^†	7^†	—
Net profit	19.4%	23.6%	115	183	88^†	68^†	51^†	40^†	29^†	11^†	13^†	20^†
EPS	19.4%	23.6%	69.64^†	110.80^†	53.01^†	40.91^†	31.13^†	24.18^†	17.54^†	—	—	—

^† Derived: the sum of that fiscal year's four quarterly filings (a real annual filing is used wherever one exists). Checked against filed annual figures, the sum lands within 0.5% for about 94% of company-years.

Annual ratios (standalone)

Ratio	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18	Mar 17
Operating margin	20.8%^†	24.4%^†	22.0%^†	20.0%^†	19.6%^†	18.0%^†	15.7%^†	10.1%^†	10.8%^†	10.1%^†
EBIT margin	21.9%^†	35.7%^†	20.3%^†	17.9%^†	16.7%^†	14.0%^†	10.2%^†	5.8%^†	7.0%^†	8.3%^†
PBT margin	21.8%	35.6%	20.2%^†	17.9%^†	16.6%^†	13.8%^†	9.7%^†	4.6%^†	5.9%^†	7.5%^†
Net margin	16.3%	28.0%	15.1%^†	13.2%^†	11.7%^†	10.3%^†	7.7%^†	3.3%^†	3.9%^†	6.7%^†
Interest coverage	174.26x^†	376.61x^†	262.87x^†	296.74x^†	141.71x^†	68.82x^†	21.83x^†	4.77x^†	6.36x^†	9.59x^†
Dividend payout	28.7%^†	14.4%^†	22.6%^†	23.5%^†	23.1%^†	0.0%^†	36.5%^†	—	—	—
Earnings retention	71.3%^†	85.6%^†	77.4%^†	76.5%^†	76.9%^†	100.0%^†	63.5%^†	—	—	—
Current ratio	3.30x	3.90x	—	—	—	—	—	—	—	—
Quick ratio	2.53x	3.12x	—	—	—	—	—	—	—	—
Debt to equity	0.03x	0.00x	—	—	—	—	—	—	—	—
Return on equity	19.0%	34.5%	—	—	—	—	—	—	—	—
Return on assets	14.5%	27.9%	—	—	—	—	—	—	—	—
Return on capital employed	24.5%^†	43.4%^†	—	—	—	—	—	—	—	—
Asset turnover	0.89x	0.99x	—	—	—	—	—	—	—	—

Margins and asset turnover use operating revenue (interest earned for banks, excluding other income), not total income. Liquidity, leverage and return ratios need a filed standalone balance sheet, which exists only for recent years; returns use year-end equity/assets. Dividend payout is shown only for companies with a dividend record. † = built from a summed fiscal year.

Revenue Mix

Data unavailable.

Cash Flow

Year ended	Operating (₹ Cr)	Investing (₹ Cr)	Financing (₹ Cr)	Capex (₹ Cr)	Free Cash Flow (₹ Cr)
March 31, 2026	56	51	-21	65	-9
March 31, 2025	78	-42	-27	36	42

Balance Sheet (standalone)

Year ended	Total Assets (₹ Cr)	Total Equity (₹ Cr)	Reserves (₹ Cr)	Borrowings, Current (₹ Cr)	Borrowings, Non-current (₹ Cr)	Current Assets (₹ Cr)	Current Liabilities (₹ Cr)	Cash & Equivalents (₹ Cr)	Net Block (₹ Cr)	Inventory (₹ Cr)
March 31, 2026	793	605	592	7	13	530	161	116	192	124
March 31, 2025	658	531	517	0	0	467	120	29	161	93

Financial charts

Trend charts drawn from the standalone income-statement and ratio tables above (oldest year on the left); a gap means that period has no figure. Annual years marked † in the tables are derived from four quarters.